Head and Neck Cancer Market: How Is HPV-Positive Oropharyngeal Cancer Reshaping the Global Treatment Paradigm?
HPV-positive oropharyngeal squamous cell carcinoma — the HPV16/18-driven malignancies now representing approximately 70% of oropharyngeal cancers in developed economies and demonstrating superior immunotherapy response rates compared to HPV-negative tumors — creates the most clinically transformative market segment, with the Head and Neck Cancer Market reflecting HPV-driven disease...
0 التعليقات 0 المشاركات 164 مشاهدة 0 معاينة